Highlights•UAE and MRgFUS are emerging as safe and effective alternatives to surgical
removal to treat symptomatic uterine fibroid.•Myomectomy remains the gold standard for …

OBJECTIVE: To determine baseline characteristics of women undergoing uterine artery
embolization (UAE) for symptomatic fibroids. DESIGN: Multicenter, prospective, single-arm …

Risk factors, both modifiable and non-modifiable, are associated with the development of
fibroids. These include age, race, endogenous and exogenous hormonal factors, obesity …

Uterine leiomyomas represent the most common pathological growth in the female
reproductive tract and will be present in about 40% of women who are still menstruating …

Uterine fibroids (leiomyomas) are common benign smooth muscle tumors of the uterus. They
are found in approximately 25% to 35% of reproductive age women [1], although detailed …

Background Uterine fibroids are common, often symptomatic and a third of women need
repeated time off work. Consequently 25% to 50% of women with fibroids receive surgical …

Background Uterine leiomyomas (fibroid tumors) cause considerable symptoms in 30–50%
of women and are the leading cause of hysterectomy in the United States. Women with …

Benign uterine fibroids, or leiomyomas, are the most common tumors found in gynecologic
practice. Symptomatic fibroids present with menorrhagia, pelvic pain, leukorrhea, pressure …

Objective: This review provides an overview of therapeutic options, with a specific focus on
the emerging role of medical options for UF management. Research design and methods …

Uterine fibroids (leiomyomas) are noncancerous growths that can have deleterious effects
on the health and quality of life for millions of women. Attempts to better understand the …